RESEARCH TRIANGLE PARK — PharPoint Research Inc. is expanding its footprint.
The provider of drug development services announced it will acquire more space for its offices in both Durham and Wilmington.
“These expansions will accommodate the company’s accelerated growth in global clinical research and consulting services and is set to bring new jobs to Durham and Wilmington as PharPoint continues to grow its diverse talent pool,” the company said in its release.
PharPoint’s Durham location has obtained an additional 6,925 square feet, now occupying the entirety of the over 22,000 square foot first floor in the Central Park South building at 5003 S. Miami Boulevard.
PharPoint’s Wilmington office has obtained an additional 2,547 square feet, now occupying over 8,600 square feet.
“North Carolina is rich with talent from its roots as a pharmaceutical hub,” Art Holmes, PharPoint Research’s President and CEO, said in a statement. “With excellent local universities expanding their clinical research curriculums, we remain committed to expanding our current offices in both Research Triangle Park and Wilmington. These expansions represent a commitment to both our customers and our staff. Our growth is a direct result of the long-lasting relationships we foster with our clients.”
At present, PharPoint Research staffs over 100 employees in their two North Carolina offices.
